In 2025, medical device manufacturers are grappling with heightened regulatory uncertainty, leading to slower reviews and communication difficulties with the FDA. This situation drives them to reassess operations for compliance and risk management, with a strong emphasis on maintaining product quality, which is vital for patient safety.
Why it Pays to Prioritize Quality Amid Regulatory Uncertainty
Related Posts
America Makes Honors 2025 Award Recipients During MMX
America Makes, the National Additive Manufacturing (AM) Innovation Institute, announced the recipients of its 2025 Ambassador Awards and…
Department of Commerce Announces Transition of Baldrige Performance Excellence Program
The U.S. Department of Commerce’s National Institute of Standards and Technology (NIST) has finalized agreements with the Alliance…
Product Definition and Regulations
This article explains how a Quality leader can establish external requirements by defining products in a specific region,…